key: cord-0773192-jnepkgi5 authors: Li, Yi; Deng, Wenyue; Xiong, Hao; Li, Hui; Chen, Zhi; Nie, Yingming; Wang, Zhuo; Li, Kaili; Li, Jianxin title: Immune‐related Factors Associated with Pneumonia in 127 Children with Coronavirus Disease 2019 in Wuhan date: 2020-06-16 journal: Pediatr Pulmonol DOI: 10.1002/ppul.24907 sha: ad01d8a0ab88d0f8763634d4b1f01651b58011b6 doc_id: 773192 cord_uid: jnepkgi5 OBJECTIVE: Information regarding the association of immune‐related factors with pneumonia in children with coronavirus disease 2019 (COVID‐19) is scarce. This study aims to summarize the immune‐related factors and their association with pneumonia in children with COVID‐19. METHODS: Children with COVID‐19 at Wuhan Children's Hospital from January 28 to March 12, 2020 were enrolled. Pneumonia due to causes other than COVID‐19 were excluded. The clinical and laboratory information including routine blood tests, blood biochemistry, lymphocyte subsets, immunoglobulins, cytokines and inflammatory factors were analyzed retrospectively in 127 patients. Normal ranges and mean values of laboratory markers were applied as parameters for logistic regression analyses of their association with pneumonia. RESULTS: In non‐intensive care unit patients, 48.8% and 22.4% of patients had increased levels of procalcitonin and hypersensitive C‐reactive protein (hs‐CRP) respectively. 12.6% and 18.1% of patients had decreased levels of immunoglobulin (Ig) A and interleukin (IL)‐10 respectively. Approximately 65.8% of patients had pneumonia. These patients had decreased levels of globulin (odds ratio [OR] 3.13, 95% confidence interval [CI] 1.41‐6.93, P=0.005), IgA (OR 4.00, 95% CI 1.13‐14.18, P=0.032), and increased levels of hs‐CRP (OR 3.14, 95% CI 1.34‐7.36, P=0.008), procalcitonin (OR 3.83, 95% CI 2.03‐7.24, P<0.001), IL‐10 (OR 7.0, 95% CI 1.59‐30.80, P=0.010), and CD4+CD25+ T lymphocyte < 5.0 % (OR 1.93, 95% CI 1.04‐3.61, P=0.038). CONCLUSION: Decreased IgA and CD4+CD25+ T lymphocyte percentage, and increased hs‐CRP, procalcitonin and IL‐10 were associated with pneumonia, suggesting that the immune‐related factors may participate in the pathogenesis of pneumonia in children with COVID‐19. This article is protected by copyright. All rights reserved. The clinical, laboratory and radiological data of the patients were obtained from the electronic medical records. Clinical information included previous medical history and management data. Laboratory information on admission included routine blood tests, serum blood biochemistry, whole blood lymphocyte subsets (T IgM), serum complement proteins (C3 and C4), plasma cytokine profiles (IL-2, IL-4, IL-6, IL-10, tumor necrosis factor [TNF]-α, and interferon [IFN]-γ) and serum inflammatory factors (hypersensitive C-reactive protein [hs-CRP], ferritin, and procalcitonin). Radiological data of the patients were examined using chest computed tomography (Siemens medical system; Siemens, Germany). In addition, information regarding influenza A and influenza B, respiratory syncytial virus, adenovirus, cytomegalovirus, Epstein-Barr virus, mycoplasma, and bacteria was also collected. The routine blood work was carried out using hemocytometer (XN-3000, Sysmex Corp., Kobe, Japan). Blood biochemistry was tested using an automatic biochemical analyzer (VITROS5600, Ortho Clinical Diagnostics, Raritan, NJ, USA). Lymphocyte subsets and cytokines were analyzed using a FACSCanto flow Accepted Article cytometer (BD FACSCanto, BD Biosciences, Franklin Lakes, NJ, USA). Immunoglobulins and complement proteins were examined by immunofixation electrophoresis (BNII, Siemens, Germany) and hs-CRP was examined by nephelometry immunoassay (BNII, Siemens, Germany). Ferritin and procalcitonin were tested by chemiluminescent immunoassay (CL-6000i, Mindray, Shenzhen, China). The RT-PCR assay and diagnostic criteria of SARS-CoV-2 were in accordance with the protocol established by the WHO 11 . Serology of other pathogens were tested by enzyme-linked immunosorbent assay (URANUS95, Aikang, Shenzhen, China). Bacteria were detected from sputum culture. The treatment regime for children with COVID-2019 was based on the National Recommendations for Diagnosis and Treatment of COVID-2019 (seventh edition) 10 . The primary antiviral regime included interferon-α2b nebulization, intravenous ribavirin, oral oseltamivir and arbidol (an anti-viral drug). Initially, intravenous methylprednisolone (1-2 mg/kg/day, for 3-5 days) was administered to patients with severe form of the disease. Subsequently, a dose-tapering course of oral prednisolone was prescribed in the following two weeks. Continuous variables were expressed as medians and interquartile range (IQR) values. Categorical variables were presented as numbers and percentages. Continuous variables were compared using independent group t-tests when the data were distributed normally. Mann-Whitney test was used when the data were not normally distributed. Categorical variables were compared using chi-squared This article is protected by copyright. All rights reserved. test or Fisher's exact test when the data were limited. Univariate and multivariate analysis with stepwise logistic regression were performed to identify the association with pneumonia. All abnormal laboratory markers and age were used as candidate associated factors. The normal range and mean values of the markers were applied as parameters for the univariate model. Significant factors of univariate analysis were then tested in the multivariate model. All statistical analyses were performed using Version 23.0 of SPSS Software. Statistical significance was defined as a two-sided P-value of less than 0.05. A total of 127 children with COVID-19 were included in the present study. The median age of patients was 6 years (IQR: 1-9 years, range: 2 months to 15 years. therapy. Detailed information was displayed in Table 1 and 2. We compared the laboratory features among children stratified by age (median 6 years) and the results are showed in Table S1 . Table 2 The patient who survived showed no B cells (0 cells/µL) but did not had an immunoglobulin result. The patient who could not survive showed hypogammaglobulinemia (IgG=1.52 g/L) with a normal count of B cells (820 cells/µL). The plasma concentration of cytokines IL-6, IL-10 and inflammatory factor ferritin markedly increased with the development of the disease (Figure 1 ). Other detailed information has been reported previously 3; 8 . Nearly two thirds of the patients (65.8%) presented with pneumonia on chest radiologic findings. We used median age (6 years) and abnormal laboratory markers to evaluate their association with pneumonia in the chest radiologic findings. Univariate analysis showed that decreased levels of globulin, IgA, and CD4+CD25+ T lymphocyte percentage (<5.0 %), and increased levels of hs-CRP, procalcitonin and IL-10 (normal ranges were showed in Table 2 ) were associated with pneumonia in chest radiologic findings among patients with COVID-19 (Table 3) . However, the multivariate analysis showed no associations. Some information was missing in some of the patients including chest radiologic findings, procalcitonin, ferritin, immunoglobulins, cytokines, and lymphocyte subsets due to the retrospective study design (Table S1 ). The present retrospective study showed that children in Wuhan who were laboratory-confirmed COVID-19 experienced a mild clinical course. The present study identified several factors associated with pneumonia in children with COVID-19. Particularly, decreased levels of globulin, IgA, and CD4+CD25+ T lymphocyte percentage (<5.0 %) and increased concentration of hs-CRP, procalcitonin, and IL-10 were associated with the presentation of pneumonia in chest radiologic findings. Pulmonary infection is the most common presentation of antibody deficiencies in children 12 . In the present study, 20/120 patients had low level of one immunoglobulin, and decreased IgA levels were associated with pneumonia. IgA has many functions, serving as a first-line barrier that protects the mucosal epithelium from pathogens 13 . In the present study, decreased IgA levels might have reduced the capability for antiviral defence in children with COVID-19. The present study has some limitations. Due to the retrospective study design, not all examinations were performed and monitored during hospitalization in all patients. Therefore, the risk factors predicting for pneumonia might be underestimated. All patients were diagnosed through RT-PCR using throat or nasopharyngeal specimens. The viremia of patients was not evaluated for technical reasons. The factors associated with pneumonia were limited by the sample size and there were only two ICU patients in this study. In conclusion, children with COVID-19 in Wuhan experienced a mild clinical course. Increased concentrations of procalcitonin, hs-CRP, and IL-10 and decreased IgA level, and percentage of CD4+CD25+ T lymphocyte were associated with pneumonia in children with COVID-19. Our results suggest that immune-related factors may participate in the pathogenesis of pneumonia in children with COVID-19. Coronavirus disease (covid-2019) situation reports-51 Clinical and ct features in pediatric patients with covid-19 infection: Different points from adults SARS-CoV-2 Infection in Children Cytokine storms in infectious diseases Clinical features of patients infected with 2019 novel coronavirus in wuhan, china Dysregulation of immune response in patients with covid-19 in wuhan, china Clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, china: A retrospective cohort study Clinical features of severe pediatric patients with coronavirus disease 2019 in wuhan: A single center's observational study Clinical management of severe acute respiratory infection when novel coronavirus (ncov) infection is suspected: Interim guidance National recommendations for diagnosis and treatment of covid-19 (the 7th edition). National health commission of people's republic of china Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease. Pediatric allergy and immunology: official publication of the Re-thinking the functions of iga(+) plasma cells Mers-cov infection in humans is associated with a pro-inflammatory th1 and th17 cytokine profile Bhlhe40 is an essential repressor of il-10 during mycobacterium tuberculosis infection Il-10 impairs local immune response in lung granulomas and lymph nodes during early mycobacterium tuberculosis infection Foxp3+ regulatory t cells in the human immune system Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan Children hospitalized with severe acute respiratory syndrome-related illness in toronto Inflammatory cytokine profile in children with severe acute respiratory syndrome The authors thank all the health care providers at the confirmed isolation wards and technical assistance of the technicians at Wuhan Children's Hospital. The authors declare that there are no conflict of interests.